Betashares Global Royalties ETF (ASX:ROYL)
11.65
+0.05 (0.43%)
At close: May 1, 2025, 4:00 PM AEST
27.04% (1Y)
Assets | 12.96M |
Expense Ratio | 0.69% |
PE Ratio | 30.17 |
Dividend (ttm) | 0.35 |
Dividend Yield | 3.04% |
Ex-Dividend Date | May 1, 2025 |
Payout Frequency | Monthly |
Payout Ratio | n/a |
1-Year Return | +26.50% |
Volume | n/a |
Open | 11.65 |
Previous Close | 11.60 |
Day's Range | 11.65 - 11.65 |
52-Week Low | 9.08 |
52-Week High | 12.11 |
Beta | n/a |
Holdings | 41 |
Inception Date | Sep 9, 2022 |
About ROYL
ROYL.AX was created on 2022-09-09 by BetaShares. The fund's investment portfolio concentrates primarily on theme equity. The investment objective of the Fund is to provide an investment return that aims to track the performance of the Solactive Global Royalties Index (the Index), before taking into account fees and expenses.
Asset Class Equity
Category Theme
Stock Exchange Australian Securities Exchange
Ticker Symbol ROYL
Provider BetaShares
Index Tracked Solactive Global Royalties Index - AUD - Benchmark TR Net
Performance
ROYL had a total return of 26.50% in the past year, including dividends. Since the fund's inception, the average annual return has been 14.92%.
Top 10 Holdings
78.46% of assetsName | Symbol | Weight |
---|---|---|
FRANCO-NEVADA CORP | FNV CT | 12.40% |
WHEATON PRECIOUS METALS CORP | WPM CT | 12.19% |
Texas Pacific Land Corporation | TPL | 12.06% |
UNIVERSAL MUSIC GROUP NV | UMG NA | 9.76% |
Arm Holdings plc | ARM | 6.69% |
GENMAB A/S | GMAB DC | 6.68% |
Royalty Pharma plc | RPRX | 6.34% |
Royal Gold, Inc. | RGLD | 5.99% |
Halozyme Therapeutics, Inc. | HALO | 3.86% |
InterDigital, Inc. | IDCC | 2.50% |
Dividend History
Ex-Dividend | Amount | Pay Date |
---|---|---|
May 1, 2025 | 0.0564 AUD | May 16, 2025 |
Apr 1, 2025 | 0.0564 AUD | Apr 16, 2025 |
Mar 3, 2025 | 0.0564 AUD | Mar 18, 2025 |
Feb 3, 2025 | 0.0564 AUD | Feb 18, 2025 |
Jan 2, 2025 | 0.0564 AUD | Jan 17, 2025 |
Jul 1, 2024 | 0.12624 AUD | Jul 16, 2024 |